Sandu Pharmaceuticals Ltd

NSE: SANDUPHQ · BSE: 524703 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹36.82
Market cap: ₹35.57 Cr
Revenue (annual): ₹69.93 Cr
Net profit (annual): ₹1.77 Cr
P/E (TTM): 14.6×Sector 47.3×
Promoter holding: 37.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 6 Financial Results 3 Board Meeting Date 3 Management Change 2 Annual General Meeting 2 Legal & Regulatory 1 Fund Raise 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

20 Apr 2026 16:02 IST BSE

Debt & Borrowing

Sandu Pharmaceuticals Debt & Borrowing

Sandu Pharmaceuticals Limited disclosed that it does not qualify as a Large Corporate under SEBI norms for the financial year ended March 31, 2026. The company reported zero outstanding long-term borrowings as of the reporting date.

Read the filing ↗